Relapsed granulomatosis with polyangiitis with panhypopituitarism.

MedStar author(s):
Citation: BMJ Case Reports. 14(1), 2021 Jan 28.PMID: 33509867Institution: MedStar Washington Hospital CenterDepartment: MedStar Georgetown University Hospital Residents | NeurologyForm of publication: Journal ArticleMedline article type(s): Journal ArticleSubject headings: *Adrenal Insufficiency/di [Diagnosis] | *Diabetes Insipidus/di [Diagnosis] | *Granulomatosis with Polyangiitis/dg [Diagnostic Imaging] | *Hypogonadism/di [Diagnosis] | *Hypopituitarism/di [Diagnosis] | *Hypothyroidism/di [Diagnosis] | *Rhinitis/dg [Diagnostic Imaging] | *Sinusitis/dg [Diagnostic Imaging] | Adrenal Insufficiency/dt [Drug Therapy] | Adrenal Insufficiency/et [Etiology] | Androgens/tu [Therapeutic Use] | Diabetes Insipidus/et [Etiology] | Fatigue/et [Etiology] | Glucocorticoids/tu [Therapeutic Use] | Granulomatosis with Polyangiitis/co [Complications] | Granulomatosis with Polyangiitis/dt [Drug Therapy] | Granulomatosis with Polyangiitis/pa [Pathology] | Hormone Replacement Therapy | Humans | Hypogonadism/dt [Drug Therapy] | Hypogonadism/et [Etiology] | Hypopituitarism/dt [Drug Therapy] | Hypopituitarism/et [Etiology] | Hypothyroidism/dt [Drug Therapy] | Hypothyroidism/et [Etiology] | Immunosuppressive Agents/tu [Therapeutic Use] | Magnetic Resonance Imaging | Male | Methotrexate/tu [Therapeutic Use] | Middle Aged | Pituitary Diseases | Pituitary Gland/dg [Diagnostic Imaging] | Recurrence | Rhinitis/pa [Pathology] | Sella Turcica/dg [Diagnostic Imaging] | Sinusitis/pa [Pathology] | Testosterone/tu [Therapeutic Use] | Thyroxine/tu [Therapeutic Use] | Weight LossYear: 2021ISSN:
  • 1757-790X
Name of journal: BMJ case reportsAbstract: A man in his early 60s with a medical history of granulomatosis with polyangiitis (GPA) in remission for two decades without maintenance therapy presented with non-specific complaints of profound fatigue and 40-pound weight loss. He was seronegative for antinuclear antibodies and cytoplasmic antineutrophilic antibodies, but erythrocyte sedimentation rate and C reactive protein levels were elevated. Endocrinological testing revealed adrenal insufficiency, hypogonadism, hypothyroidism and diabetes insipidus. An MRI of the head revealed extensive sinonasal inflammation eroding through the floor of the sella turcica and into the pituitary gland and stalk. Biopsy of the sinonasal tissues was inconclusive. On review of his case, a multidisciplinary team diagnosed him with panhypopituitarism secondary to a recurrence of GPA. He responded well to glucocorticoids and methotrexate with marked reduction of pituitary enhancement on imaging and resolution of diabetes insipidus. He will require lifelong testosterone, levothyroxine and glucocorticoids for hormone replacement therapy. Copyright (c) BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ.All authors: Haberstroh WD, Lenka A, Triano MJ, Whelton SAOriginally published: BMJ Case Reports. 14(1), 2021 Jan 28.Fiscal year: FY2021Digital Object Identifier: Date added to catalog: 2021-02-17
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 33509867 Available 33509867

A man in his early 60s with a medical history of granulomatosis with polyangiitis (GPA) in remission for two decades without maintenance therapy presented with non-specific complaints of profound fatigue and 40-pound weight loss. He was seronegative for antinuclear antibodies and cytoplasmic antineutrophilic antibodies, but erythrocyte sedimentation rate and C reactive protein levels were elevated. Endocrinological testing revealed adrenal insufficiency, hypogonadism, hypothyroidism and diabetes insipidus. An MRI of the head revealed extensive sinonasal inflammation eroding through the floor of the sella turcica and into the pituitary gland and stalk. Biopsy of the sinonasal tissues was inconclusive. On review of his case, a multidisciplinary team diagnosed him with panhypopituitarism secondary to a recurrence of GPA. He responded well to glucocorticoids and methotrexate with marked reduction of pituitary enhancement on imaging and resolution of diabetes insipidus. He will require lifelong testosterone, levothyroxine and glucocorticoids for hormone replacement therapy. Copyright (c) BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ.

English

Powered by Koha